25 reports

Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, a market leader in virology and active in other major therapeutic areas such as autoimmune diseases, inflammation, metabolic disorders and diseases of the central nervous system.

  • Brain Cancer
  • China
  • Demand
  • ACON Biotech Co., Ltd
  • Bayer Schering Pharmaceutical Co., Ltd

Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, a market leader in virology and active in other major therapeutic areas such as autoimmune diseases, inflammation, metabolic disorders and diseases of the central nervous system.

  • Brain Cancer
  • China
  • ACON Biotech Co., Ltd
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd

The company' s products are used for the treatment and detection of cancers, the treatment of inflammatory, autoimmune diseases, and ischemic heart disease.

  • Brain Cancer
  • World
  • Litigation And Patent
  • Product Initiative
  • Cellmid Limited
  • VACCINE FOR AUTOIMMUNE DISEASES, GLIOBLASTOMA MULTIFORME AND MULTIPLE MYELOMA - DRUG PROFILE
  • VACCINE TO TARGET SURVIVIN FOR AUTOIMMUNE DISEASES, GLIOBLASTOMA MULTIFORME AND MULTIPLE MYELOMA - DRUG PROFILE

Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) - Pipeline Review, H2 2018 Summary Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) pipeline Target constitutes close to 21 molecules....

  • Brain Cancer
  • Oncology
  • United States
  • Product Initiative
  • Immunovaccine Inc.
  • VACCINE TO TARGET SURVIVIN FOR AUTOIMMUNE DISEASES, GLIOBLASTOMA MULTIFORME AND MULTIPLE MYELOMA - DRUG PROFILE
  • PIPELINE BY MIMIVAX LLC, H1 2018

Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) - Pipeline Review, H1 2018 Summary Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) - Baculoviral inhibitor of apoptosis repeat-containing...

  • Brain Cancer
  • Hospital
  • Oncology
  • Therapy
  • Immunovaccine Inc.

It has collaboration with various pharmaceutical companies, to develop its product candidates through its GLAAS platform for the treatment of infectious disease, allergy and autoimmune diseases.

  • Brain Cancer
  • Digestive System Disorder
  • Hospital
  • Therapy
  • MediciNova, Inc.

Deciphera Pharmaceuticals products are used in the treatment of renal and colon cancers, mastocytosis, gastrointestinal stromal tumors, crohn' s disease and autoimmune nephritis, solid tumors, rheumatoid arthritis, and others.

  • Brain Cancer
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative

Patients with active autoimmune disease or a medical condition that required immunosuppression or with clinical evidence of ascites by physical exam were ineligible.

  • Brain Cancer
  • Cancer
  • United States
  • Product Initiative
  • Merck & Co., Inc.
  • 5. All the trials included are unique trials.

The report includes coverage of disease clinical trials by region and top countries, trial phase, trial status, end points status and sponsor type.

  • Brain Cancer
  • Hospital
  • Therapy
  • World
  • Product Initiative

Over a ## month follow-up, ## (##%) patients had stable disease and six (##%) had progressive disease.

  • Brain Cancer
  • Lymphoma
  • United States
  • Product Initiative
  • Merck & Co., Inc.
  • CLINICAL TRIAL PROFILE SNAPSHOTS

The report includes coverage of disease clinical trials by region and top countries, trial phase, trial status, end points status and sponsor type.

  • Brain Cancer
  • Drug Discovery And Development
  • Oncology
  • World
  • Product Initiative

It focuses on therapy areas such as respiratory, inflammation, autoimmune disease (RIA); cardiovascular and metabolic disease (CVMD); and cancer, besides infection and AZN PARTNER ##: ASTRAZENECA PLC COMPANY INFORMATION: PARTNERS Industry neurological

  • Brain Cancer
  • Cancer
  • Pharmaceutical
  • Therapy
  • Ionis Pharmaceuticals, Inc.

It focuses on therapy areas such as respiratory, inflammation, autoimmune disease (RIA); cardiovascular and metabolic disease (CVMD); and cancer, besides infection and AZN PARTNER ##: ASTRAZENECA PLC COMPANY INFORMATION: PARTNERS Industry neurological

  • Brain Cancer
  • Cancer
  • Pharmaceutical
  • Therapy
  • Ionis Pharmaceuticals, Inc.

It develops products for the treatment of cancer, autoimmune diseases, multiple sclerosis, and post-operative pain therapeutics.

  • Brain Cancer
  • Cancer
  • Hospital
  • Therapy
  • Bristol-Myers Squibb Company

It develops products for the treatment of cancer, autoimmune diseases, multiple sclerosis, and post-operative pain therapeutics.

  • Brain Cancer
  • Cancer
  • Hospital
  • Therapy
  • Bristol-Myers Squibb Company

The best overall response was one partial response and one stable disease in these three patients.

  • Brain Cancer
  • Cancer
  • United States
  • Product Initiative
  • Pfizer Inc.
  • MIDATECH PHARMA PLC
  • PONTINE GLIOMA - PIPELINE BY MIDATECH PHARMA PLC, H1 2018

It focuses on therapy areas such as respiratory; cardiovascular and renal and metabolic diseases; and cancer, besides autoimmune, infection and neurological diseases.

  • Brain Cancer
  • Cancer
  • Hospital
  • Therapy
  • Bristol-Myers Squibb Company
  • PONTINE GLIOMA - PIPELINE BY MIDATECH PHARMA PLC, H2 2017
  • PONTINE GLIOMA - PIPELINE BY MEDICENNA THERAPEUTICS CORP, H2 2017

It focuses on therapy areas such as respiratory; cardiovascular and metabolic disease (CVMD); and cancer, besides autoimmune, infection and neurological diseases.

  • Brain Cancer
  • Cancer
  • United States
  • Product Initiative
  • Bristol-Myers Squibb Company

ONLY ## PATIENT HAD PROGRESSIVE DISEASE.

  • Brain Cancer
  • Therapy
  • United States
  • Product Initiative
  • Bristol-Myers Squibb Company

The collaboration calls for scientists at Rockefeller to use Hemogenyx' s new type of humanized mice for autoimmune disease modelling in an effort to develop new treatments for autoimmune diseases, specifically lupus.

  • Brain Cancer
  • Healthcare
  • Pharmaceutical
  • Therapy
  • Pfizer Inc.

Sorrento Therapeutics Inc (STI), formerly QuikByte Software Inc is a biopharmaceutical company that develops novel treatments for cancer, inflammation and autoimmune diseases.

  • Brain Cancer
  • Lung Cancer
  • United States
  • Product Initiative
  • Bristol-Myers Squibb Company

The collaboration calls for scientists at Rockefeller to use Hemogenyx' s new type of humanized mice for autoimmune disease modelling in an effort to develop new treatments for autoimmune diseases, specifically lupus.

  • Brain Cancer
  • Healthcare
  • Pharmaceutical
  • Therapy
  • Pfizer Inc.
  • RECURRENT GLIOBLASTOMA MULTIFORME (GBM) - PIPELINE BY KARYOPHARM THERAPEUTICS, INC., H1 2016

It offers prescription medicines for treating cardiovascular, metabolic, respiratory, cancer, inflammation, autoimmune, infection and neuroscience diseases.

  • Brain Cancer
  • Hospital
  • Targeted Therapy
  • Therapy
  • Merck & Co., Inc.
  • BRAIN CANCER - PIPELINE BY LIPOCURE LTD., H2 2015
  • BRAIN CANCER - PIPELINE BY HUTCHISON MEDIPHARMA LIMITED, H2 2015

Brain Cancer - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Brain Cancer - Pipeline Review, H2 2015’, provides an overview of the Brain Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Brain Cancer, complete with comparative analysis...

  • Brain Cancer
  • Monoclonal Antibody
  • Pharmaceutical
  • Therapy
  • Exelixis, Inc.
  • RECURRENT GLIOBLASTOMA MULTIFORME (GBM) - PIPELINE BY KARYOPHARM THERAPEUTICS, INC., H2 2016
  • KADMON CORPORATION, LLC

Its pipeline of SINE compounds also intended for the treatment of viral indications, wound-healing, neurological disorders, inflammation and autoimmune diseases.

  • Brain Cancer
  • Cancer
  • United States
  • Product Initiative
  • Merck & Co., Inc.